Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Polyphosphate kinase targeting inhibitor J17

A technology of polyphosphate and inhibitor, which is applied in the direction of medical preparations containing active ingredients, pharmaceutical formulas, antibacterial drugs, etc., and can solve serious problems such as drug resistance

Pending Publication Date: 2019-09-10
THE FIFTH AFFILIATED HOSPITAL OF GUANGZHOU MEDICAL UNIV +1
View PDF1 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Urinary tract infection caused by UPEC is mainly treated with antibiotics, but with the widespread use of antibiotics, the drug resistance of UPEC is becoming more and more serious

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Polyphosphate kinase targeting inhibitor J17
  • Polyphosphate kinase targeting inhibitor J17
  • Polyphosphate kinase targeting inhibitor J17

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0030] 1. Materials

[0031] Strains and cell lines

[0032] Uropathogenic Escherichia coli CFT073 and human bladder cancer epithelial cell line 5637 were donated by Professor Huang Shenghe from the Children's Hospital of Los Angeles, University of Southern California. The ppk1 knockout strain (△pk1) of CFT073 was constructed and preserved in our laboratory.

[0033] 2. Reagents

[0034] LB medium was purchased from OXOID Company in the UK; PBS powder was purchased from Boster Biological Company; DMSO was purchased from Sigma Company; RPMI-1640 medium, fetal bovine serum (FBS) and trypsin were purchased from Gibco Company; 30% hydrogen peroxide The solution was purchased from Guangzhou Zhongnan Chemical Reagent Company; acridine orange (AO) was purchased from Solarbio Company; absolute ethanol, glacial acetic acid, and chloroform were purchased from Guangzhou Panyu Liqiang Chemical.

[0035] 3. Method

[0036] 3.1 Computer virtual screening

[0037] use Suite 2019 prepar...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a polyphosphate kinase targeting inhibitor. The polyphosphate kinase targeting inhibitor is a compound J17, the molecular formula is C15H11OF3Cl, and the structural formula isshown in the formula (I). The polyphosphate kinase targeting inhibitor can inhibit the resistance of pathogenicity escherichia coli of the urinary tract to oxidation pressure, the formation of a biological membrane of the pathogenicity escherichia coli of the urinary tract and the invasion function of the pathogenicity escherichia coli of the urinary tract to epithelial cells of the urinary tract. The polyphosphate kinase targeting inhibitor is expected to be prepared into drugs which are applied to treatment of infection of the urinary tract.

Description

technical field [0001] The invention belongs to the technical field of targeting compounds, and more specifically, the invention relates to a polyphosphate kinase targeting inhibitor. Background technique [0002] Urinary tract infection is one of the clinical frequently-occurring infectious diseases, and its pathogenic bacteria include Escherichia coli, Enterococcus, Proteus mirabilis, Klebsiella pneumoniae, Pseudomonas aeruginosa and fungi, among which Escherichia coli Escherichia is the most common. Escherichia coli that cause urinary tract infections are collectively referred to as uropathogenic Escherichia coli (UPEC). Clinically, antibiotics are the main treatment for urinary tract infection caused by UPEC, but with the widespread use of antibiotics, the drug resistance of UPEC is becoming more and more serious. UTIs caused by UPEC are also characterized by female susceptibility and repeated infections. If not effectively treated, it can further cause serious consequ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/167A61P31/04A61P13/02
CPCA61K31/167A61P31/04A61P13/02Y02A50/30
Inventor 彭亮金宏威孙宁曾李婷肖仪
Owner THE FIFTH AFFILIATED HOSPITAL OF GUANGZHOU MEDICAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com